A study was undertaken to investigate recent reports concerning the use of transcutaneous electrostimulation (TES) for relief of postoperative pain. Thirty patients undergoing elective herniorrhaphy were subjected to a standard perianaesthetic protocol. The patients were divided into three groups of ten, designated control, sham TES and TES. Postoperative analgesic requirements for each group were compared.
(TES) means passing an electric current through the skin surface through non-penetrating conducting electrodes. It is to be distinguished from percutaneous stimulation, which means current applied through electrodes such as needles, which penetrate the skin and from transcutaneous electrical nerve stimulation which implies a specific mechanism of action of the applied current through nerves.
TES for the management of chronic pain states was first reported by Shealy in 1972 .' Since 1975, TES has been used in the Vancouver General Hospital Pain Clinic and has been found to be useful as a mode of therapy for the management of chronic pain. 2 Conflicting reports have appeared in recent medical literature concerning the use of TES for relief of acute post-operative pain. 3 " 5 This initial study was undertaken to evaluate the analgesic effects of TES in this type of pain in a clinical setting in the operation room and to determine whether it warranted a full scale trial on a larger number of postoperative patients.
TES has a number of advantages over traditional narcotic medications in the management of postoperative pain and, therefore, full evaluation of its potential is indicated. It does not depress the cardiovascular or respiratory systems and, apart from possible minor sedation, has no apparent effect on the sensorium; it is non-invasive, non-toxic, and relatively innocuous; it is simple in its application and can be used continuously or intermittently. Reduced incidence of atelectasis and ileus in the postoperative period have also been reported, but these remain unproved. 6 Apart from contact dermatitis from the electrodes or conductive gel, complications and side effects have not been reported.
METHODOLOGY

Patient selection
Thirty patients of ASA status 1 or 2* between 19 and 74 years of age who were undergoing elective herniorrhaphy were selected for this study. The patients were divided into three groups of ten, each group being comparable for age, sex, and duration of operation.
Group 1: A control group often patients was studied purely to establish baseline analgesic requirements for patients exposed to the perioperative protocol. They were not informed about the study, and they were not interviewed after the study. . These patients were seen preoperatively by one of the investigators (SB).
The study was fully explained to them, and a signed consent was obtained. Any questions concerning the study were answered, but they were not informed to which group they were being assigned. In order to obtain ten patients in each group, 40 patients were studied. Six patients were excluded because they had a recovery room score 8 of less than five (Table I) , three patients because bilateral procedures were carried out under the same anaesthetic and one patient because of severe unrelated postoperative back pain, resulting from previous traumatic lumbar spine compression fractures.
Anaesthetic and postoperative protocol
All patients received diazepam 5 to 10 mg orally as premedication, followed by a general anaesthetic without the use of narcotic. Thiopentone was used for induction followed by the muscle relaxant of anaesthetist's choice and halothane, nitrous oxide and oxygen maintenance. After reversal of the muscle relaxant patients were transferred to the post-anaesthetic recovery area where they received oxygen until awake. Thirty minutes after operation each patient was assessed and assigned a recovery room score (Table I) by the recovery room nurses, to establish the degree of wakefulness, or recovery from the anaesthetic. Patients scoring less than five out of a possible six were not included in the final patient composition of the study.
Intravenous meperidine 5.0mg, 7.5 mg, or 10.0 mg, according to patient weight (0.1 ± 0.015 mg-kg" 1 ) was ordered for postoperative Positioning of stimulating electrodes on analgesia. Administration of the analgesic was left to the discretion of the nurses, at the patient's request. All patients received the usual monitoring and observations afforded to postoperative patients and remained in the recovery room for three hours, after which they were transferred to the ward. In the ward, intramuscular meperidine (approximately l.Omgkg"') was given by the nurses for analgesia, at the patient's request.
Method of stimulation
Immediately after operation each patient in groups 2 and 3 had four standard adult electroencephalogram electrodes attached to the skin ( ( Figure 4) . The amplitude ranged from 3.0 to 6.0 volts peak to peak voltage. The current range was 3.0 to 6.0 milliamperes with an average skin resistence of 1000ohms, which was well below the accepted fibrillation threshold of 75 milliamperes. 9 In group 3, the T E S group, the amplitude was preset at the minimum voltage until patients were awake, then it was increased until they were able to appreciate a comfortable tingling sensation.
In group 2, the sham T E S group, altered leads were used so that the patient received no current despite the stimulating machine being switched on, and the amplitude dial was varied as in group 3 patients. The TES and sham TES were discontinued after the three hours in the recovery room.
ASSESSMENT
Analgesic requirement for each patient for the first twenty-four postoperative hours was recorded. The number of intravenous doses of meperidine given in the recovery room (up to three hours) and the number of intramuscular doses given in the ward (up to 24 hours) were totalled separately. A subjective assessment was requested from each patient and the nurses' comments on any particular features were noted.
RESULTS
Analgesic requirements
The number of intravenous doses of meperidine given to the patients in the three groups in the first three hours was: control group 46 doses, sham TES group 38 doses, TES group 10 doses ( Figure 5 ). The TES group is significantly different from the control group (p < 0.0005) and the sham TES group (p < 0.0025) when compared by the Student's t-test.
The number of intramuscular doses of meperidine given to the patients in the three-to twenty-four-hour period was: control group 21 doses, sham TES group 22 doses, TES group 17 doses ( Figure 6 ). There is no statistical difference between these groups when compared by the Student's t-test.
The range of doses is shown by the individual analgesic requirements of patients in the three groups in Table II .
Subjective assessment
In the TES group, eight patients felt that they had benefitted from TES and two could not decide because they lacked comparative incidents. Five of this group noted particularly that they had been given analgesic medication at night when they had no pain. Two patients recalled awakening from their anaesthetics with some pain but within 15 to 20 minutes of feeling TES they were completely comfortable
In the sham TES group, no patients felt that they received benefit. Eight patients stated that they did not receive benefit and two patients stated that (sham) TES had made their pain worse. The nurses noted that three of the patients were more restless than other patients from the study whom they had nursed. One patient who had had previous beneficial acupuncture experience felt disappointed that (sham) TES had not worked as he had anticipated. Another patient having sham TES recalled far more pain following this herniorrhaphy when compared with previous similar surgery.
DISCUSSION
These results have shown that the analgesic requirement of patients in the TES group is considerably less than the control and sham TES groups in the first three hours after operation. The subjective assessment of the postoperative discomfort was also less in the TES group. The fact that five of the ten patients in the TES group required no analgesic medication in the three hour recovery room stay is an encouraging trend. If this could be duplicated in a group of respiratory or cardiovascular compromised patients, it would certainly be of benefit to them.
The analgesic effect of TES after the stimulation was discontinued in this study did not appear to be of sufficient duration to reduce the medication requirement significantly. It was the subjective impression of the interviewer (S.B.) that patients in the sham TES and TES groups had similar discomfort after the first one to two hours back in the ward. The value of continuing TES for longer than three hours to extend the analgesic effect needs to be studied further.
Although the results appear significant in this small study, there were a number of factors which were not easily controllable. Pain is a subjective interpretation of nociceptive input, so that each patient will have a different appreciation of pain and pain threshold from equivalent surgical stimulus. Therefore individual analgesic requirements will vary considerably. The subjective interpretation of the patient's symptoms by the nurses administering the analgesics create further variation. Until we can measure pain quantitatively this individual variation will remain a problem in any pain research.
Once the patients were fully awake the frequency of observations by the recovery room nurses tended to vary according to the nurses' workload and the amount of attention sought by the patients. The fact that the nurses and patients were participating in an experimental method which they were told might produce analgesia could have influenced the amount of analgesic drugs administered, particularly as they were all unaware that sham stimulation was being carried out. On the ward, again, frequency of patient contact by nurses and criteria for administering analgesics were extremely variable. On many occasions patients were given analgesics for sleep, or routinely following nocturnal recording of vital signs when, in fact, they had no pain. There is a need for more critical evaluation of the use of narcotic analgesics in postoperative pain management, particularly in the ward situation.
The mechanism of action of transcutaneous electrostimulation has not been completely clarified. Its action may be explained by modification of pain impulses 10 at the spinal cord, midbrain or thalamic levels, or by release of endorphins which may initiate a central descending inhibitory mechanism." 12 The exact role of placebo is difficult to assess and, although it may play a part, it is difficult to quantify.
CONCLUSION
Transcutaneous electrostimulation significantly reduced the immediate postoperative analgesic requirement in these patients undergoing herniorrhaphy. Further investigation of this mode of analgesic therapy is indicated to define more clearly its pattern of application and its role in the management of pain in the postoperative period.
A working study protocol has been established for use in future studies. The recovery room nurses have been familiarized with the equipment used and the surgeons, anaesthetists and nurses involved here accepted both the principle and the technique of transcutaneous electrostimulation.
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